NCT03697590 is a Phase 4 clinical trial of No curettage in Keratosis, Actinic, sponsored by Bispebjerg Hospital.

Who is sponsoring NCT03697590?

NCT03697590 is sponsored by Bispebjerg Hospital.

What drugs are being tested in NCT03697590?

Interventions in NCT03697590: No curettage, Curettage.

What condition does NCT03697590 study?

NCT03697590 studies Keratosis, Actinic.

Is NCT03697590 still recruiting?

NCT03697590 is currently completed. Last updated 9 October 2018.

Last reviewed 2018-10-09 · How we verify

NCT03697590

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Photodynamic Therapy of Actinic Keratosis of the Face and Scalp With and Without Prior Curettage

Completed Phase 4 Last updated 9 October 2018

What this trial tests

Phase 4 trial testing No curettage in Keratosis, Actinic in 25 participants. Completed in 20 December 2017.

Timeline

1 June 2017

Primary endpoint
20 December 2017

20 December 2017

Quick facts

Lead sponsor	Bispebjerg Hospital
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	25
Start date	1 June 2017
Primary completion	20 December 2017
Estimated completion	20 December 2017
Sites	1 location across Denmark

Drugs / interventions tested

No curettage — full drug profile →
Curettage — full drug profile →

Conditions studied

Keratosis, Actinic — all drugs for Keratosis, Actinic →

Sponsor

Bispebjerg Hospital

Who can join

18 and older, any sex, with Keratosis, Actinic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Guidelines for photodynamic therapy (PDT) of actinic keratosis recommend pretreatment with curettage. The impact of curettage on the treatment effect is, however, not known. The present study aimed to evaluate whether daylight-PDT without curettage would reduce treatment effect compared to daylight-PDT with curettage.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Keratosis, Actinic

Currently open trials in the same condition.

NCT05636800 — Microwave Treatment for Actinic Keratosis · NA · active not recruiting

Other Bispebjerg Hospital trials

Trials by the same sponsor.

NCT06872060 — The Effects of Glucagon on Renal Regional Blood Flow in Humans Measured by Magnetic Resonance. · NA · not yet recruiting
NCT07373587 — Preventing Hospital Associated Disability in Older Patients: Individualized Nutrition and Exercise Strategy · NA · not yet recruiting
NCT07123558 — Anal Cancer Prevention in High-Risk Categories of Men Who Have Sex With Men · NA · not yet recruiting
NCT07124338 — Preventing Hospital Associated Disability in Older Patients: Individualized Nutrition and Exercise Strategy, a Feasibili · NA · active not recruiting
NCT07096648 — Alert Burden When Monitoring Patients at Home · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03697590 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Bispebjerg Hospital
Last refreshed: 9 October 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03697590.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing